ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

CCOP Reponses So Far Indicates application To Total 150-200

August 27, 1982

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

November 26, 1993

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

October 9, 1992

FDA Likely To Change Procedures For Patient Interaction, Official Says

November 10, 1995

In Brief: Moertel To Deliver Karnofsky Lecture; Hopkins, Cold Spring Harbor Receive Bristol-Myers Awards

April 25, 1986

NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.

June 22, 2007